Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency

Author:  ["Antonio M Almeida","Yoshiko Murakami","D Mark Layton","Peter Hillmen","Gabrielle S Sellick","Yusuke Maeda","Stephen Richards","Scott Patterson","Ioannis Kotsianidis","Luigina Mollica","Dorothy H Crawford","Alastair Baker","Michael Ferguson","Irene Roberts","Richard Houlston","Taroh Kinoshita","Anastasios Karadimitris"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

Attachment to the plasma membrane by linkage to a glycosylphosphatidylinositol (GPI) anchor1 is a mode of protein expression highly conserved from protozoa to mammals2. As a clinical entity, deficiency of GPI has been recognized as paroxysmal nocturnal hemoglobinuria, an acquired clonal disorder associated with somatic mutations of the X-linked PIGA gene in hematopoietic cells3,4. We have identified a novel disease characterized by a propensity to venous thrombosis and seizures in which deficiency of GPI is inherited in an autosomal recessive manner. In two unrelated kindreds, a point mutation (c → g) at position −270 from the start codon of PIGM, a mannosyltransferase-encoding gene, disrupts binding of the transcription factor Sp1 to its cognate promoter motif. This mutation substantially reduces transcription of PIGM and blocks mannosylation of GPI, leading to partial but severe deficiency of GPI. These findings indicate that biosynthesis of GPI is essential to maintain homeostasis of blood coagulation and neurological function.

Cite this article

Almeida, A., Murakami, Y., Layton, D. et al. Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency. Nat Med 12, 846–851 (2006). https://doi.org/10.1038/nm1410

View full text

>> Full Text:   Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency

Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction

Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophre